[go: up one dir, main page]

NO961949D0 - Interdigitasjons-fusjonsliposomer inneholdende arachidonsyre metabolitter - Google Patents

Interdigitasjons-fusjonsliposomer inneholdende arachidonsyre metabolitter

Info

Publication number
NO961949D0
NO961949D0 NO961949A NO961949A NO961949D0 NO 961949 D0 NO961949 D0 NO 961949D0 NO 961949 A NO961949 A NO 961949A NO 961949 A NO961949 A NO 961949A NO 961949 D0 NO961949 D0 NO 961949D0
Authority
NO
Norway
Prior art keywords
arachidonic acid
acid metabolites
liposomes containing
interdigitation
containing arachidonic
Prior art date
Application number
NO961949A
Other languages
English (en)
Other versions
NO961949L (no
NO312808B1 (no
Inventor
Andrew Stuart Janoff
Sharma R Minchey
Original Assignee
Liposome Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Liposome Co Inc filed Critical Liposome Co Inc
Publication of NO961949L publication Critical patent/NO961949L/no
Publication of NO961949D0 publication Critical patent/NO961949D0/no
Publication of NO312808B1 publication Critical patent/NO312808B1/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/127Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/557Eicosanoids, e.g. leukotrienes or prostaglandins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/06Antigout agents, e.g. antihyperuricemic or uricosuric agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • A61P21/04Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Dispersion Chemistry (AREA)
  • Endocrinology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Obesity (AREA)
  • Immunology (AREA)
  • Emergency Medicine (AREA)
  • Neurosurgery (AREA)
  • Pulmonology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
NO19961949A 1993-11-16 1996-05-13 Interdigitasjons-fusjonsliposomer inneholdende arachidonsyremetabolitter, farmasöytisk preparat som inneholderdet samme samt fremgangsmåte for fremstilling av et medikament NO312808B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US15317693A 1993-11-16 1993-11-16
PCT/US1994/013063 WO1995013797A1 (en) 1993-11-16 1994-11-15 Interdigitation-fusion liposomes containing arachidonic acid metabolites

Publications (3)

Publication Number Publication Date
NO961949L NO961949L (no) 1996-05-13
NO961949D0 true NO961949D0 (no) 1996-05-13
NO312808B1 NO312808B1 (no) 2002-07-08

Family

ID=22546097

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19961949A NO312808B1 (no) 1993-11-16 1996-05-13 Interdigitasjons-fusjonsliposomer inneholdende arachidonsyremetabolitter, farmasöytisk preparat som inneholderdet samme samt fremgangsmåte for fremstilling av et medikament

Country Status (13)

Country Link
EP (1) EP0729352B1 (no)
JP (1) JP3798016B2 (no)
KR (1) KR960705546A (no)
AT (1) ATE176397T1 (no)
AU (1) AU681469B2 (no)
CA (1) CA2175350A1 (no)
DE (1) DE69416425T2 (no)
DK (1) DK0729352T3 (no)
ES (1) ES2126868T3 (no)
FI (1) FI962080A0 (no)
GR (1) GR3030123T3 (no)
NO (1) NO312808B1 (no)
WO (1) WO1995013797A1 (no)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU682753B2 (en) * 1994-01-11 1997-10-16 Liposome Company, Inc., The Treatment using arachidonic acid metabolite and particulate formulations
JP2003342196A (ja) * 2002-05-31 2003-12-03 Mukku:Kk 静脈注射用組成物、その製造法およびその製剤

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1988009170A1 (en) * 1987-05-22 1988-12-01 The Liposome Company, Inc. Prostaglandin-lipid formulations
US5262168A (en) * 1987-05-22 1993-11-16 The Liposome Company, Inc. Prostaglandin-lipid formulations
DK0510086T3 (da) * 1990-01-12 1997-06-09 Liposome Co Inc Interdigitarionsfusions liposomer og geler
DE69228332T2 (de) * 1991-05-07 1999-09-16 The Liposome Co.,Inc. Liposomale Prostaglandinformulierungen
JPH05139977A (ja) * 1991-05-17 1993-06-08 Green Cross Corp:The プロスタグランジン類リポソーム複合体を充填した注射器

Also Published As

Publication number Publication date
NO961949L (no) 1996-05-13
CA2175350A1 (en) 1995-05-26
DK0729352T3 (da) 1999-09-20
ES2126868T3 (es) 1999-04-01
AU681469B2 (en) 1997-08-28
WO1995013797A1 (en) 1995-05-26
JP3798016B2 (ja) 2006-07-19
EP0729352B1 (en) 1999-02-03
FI962080A7 (fi) 1996-05-15
DE69416425D1 (de) 1999-03-18
AU1055595A (en) 1995-06-06
NO312808B1 (no) 2002-07-08
GR3030123T3 (en) 1999-07-30
FI962080L (fi) 1996-05-15
DE69416425T2 (de) 1999-06-10
KR960705546A (ko) 1996-11-08
FI962080A0 (fi) 1996-05-15
JPH09505302A (ja) 1997-05-27
EP0729352A1 (en) 1996-09-04
ATE176397T1 (de) 1999-02-15

Similar Documents

Publication Publication Date Title
DK0726764T3 (da) Multilamel-liposomale arachidonsyremetabolitformuleringer
ES2145318T3 (es) Imidazo(4,5-c)quinolin-aminas.
ES2001035A6 (es) Herrete para la oreja de una animal
FI973320A7 (fi) Kiinteitä aktiiviainetta sisältäviä valmisteita
ES2148593T3 (es) Compuestos retinoides trienoicos novedosos y metodos.
DE69633293D1 (de) Für das Auge unschädliche Übertragung gefährlicher Laserstrahlen
ES2174293T3 (es) Microesferas farmaceuticas de acido valproico para la administracion oral.
AR001035A1 (es) Metodo para encarretar una tira de alambres, colocados juntos entre si, como alambres encolados.
DE69416425D1 (de) Arachidonsäuremetaboliten enthaltende interdigitations-fusions-liposomen
ES2158094T3 (es) Sales de adicion de acido de compuestos de 2,3,4,5-tetrahidro-1h-3-benzazepina.
ES2192669T3 (es) Uso de proteinas como agentes frente a enfermedades autoinmunes.
ES2141978T3 (es) Retinoides triciclicos, metodos para su produccion y uso.
IT8222566A0 (it) Derivato dell'acido ursolico farmacologicamente attivo.
DE69722178D1 (de) Therapeutischer wirkstoff für augenerkrankungen
IT8323951A0 (it) Procedimento per la sintesi di acido ursodesossicolico coniugato con la taurina.
IT1265422B1 (it) Unguento farmaceutico privo di azione irritativa della pelle e procedimento per la sua preparazione
ES2105973B1 (es) Composicion liposomal para la regeneracion celular de la piel.
UA22016A (uk) Препарат для саhації сперми бугаїв "декомсаh"
SE8207186D0 (sv) Terapeutiskt aktiva, membranstabiliserande medel
ITBO950563A0 (it) Sistema per la sostituzione di accumulatori elettrici.
GEU1998372Y (en) Medicinal Ointment “Tsimeriali” for Paradontitis
ES1030035Y (es) Dispositivo para fijar cordeles entre regles para la construccion.

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees